Skip to Main Content

Paper Details

Somatic and Germline <i>TP53</i> Alterations in Second Malignant Neoplasms from Pediatric Cancer Survivors.
Clin Cancer Res
24
2017
A639G, CCSS, G215C, Pediatric Cancer, RNA, SMN, SMNs, Second Malignant Neoplasms, Second malignant neoplasms, TP53, TP53 variant, TP53 variants, TP53-, TP53-coding exons, TP53-mutant variants, amino acid, cancer, familial cancer predisposition syndrome, germline, germline specimens, p53', patients, pediatric cancer, radiation-induced sarcomas, sarcomas, transcriptomes
Author NameAffiliation
Tali MazorUniversity of California san francisco
Mignon L LohUniversity of California san francisco
Steven G DuBoisDana Farber/Boston Children's Cancer and Blood Disorders Program and Harvard Medical School
Joseph P NegliaUniversity of Minnesota
Joseph P NegliaUniversity of Minnesota
Sue HammondNationwide Children's Hospital
Sue HammondNationwide Children's Hospital
Leslie L RobisonSt. Jude Children's Research Hospital
Leslie L RobisonSt. Jude Children's Research Hospital
Joseph F CostelloUniversity of California san francisco
Smita BhatiaUniversity of Alabama
Smita BhatiaUniversity of Alabama
  • 1 - 12

Datasets

Release 1.2